ImmunityBio, Inc.IBRXNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P18
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -16.27% |
| Q3 2025 | 21.96% |
| Q2 2025 | -10.64% |
| Q1 2025 | 7.16% |
| Q4 2024 | 13.52% |
| Q3 2024 | 19.21% |
| Q2 2024 | -4.35% |
| Q1 2024 | -11.49% |
| Q4 2023 | -6.56% |
| Q3 2023 | 5.88% |
| Q2 2023 | 23.69% |
| Q1 2023 | -32.49% |
| Q4 2022 | 7.25% |
| Q3 2022 | -14.04% |
| Q2 2022 | 17.04% |
| Q1 2022 | -21.06% |
| Q4 2021 | -0.56% |
| Q3 2021 | 8.23% |
| Q2 2021 | 0.42% |
| Q1 2021 | -179.30% |
| Q4 2020 | 53.12% |
| Q3 2020 | -29.38% |
| Q2 2020 | -38.73% |
| Q1 2020 | -78.17% |
| Q4 2019 | -32.25% |
| Q3 2019 | 6.62% |
| Q2 2019 | 6.91% |
| Q1 2019 | -3.43% |
| Q4 2018 | 26.64% |
| Q3 2018 | 14.90% |
| Q2 2018 | -0.50% |
| Q1 2018 | -12.12% |
| Q4 2017 | -4.01% |
| Q3 2017 | -1.08% |
| Q2 2017 | 4.70% |
| Q1 2017 | -0.93% |
| Q4 2016 | 23.72% |
| Q3 2016 | 6.73% |
| Q2 2016 | -11.15% |
| Q1 2016 | 60.07% |